Analysis for DOC

📈 Growth & Financial Trajectory

8 quarters show a positive revenue trajectory, with Revenues rising from roughly $694M in 2025 Q2 to about $771.6M in 2026 Q2, a gain near 11-12%. Net Income improves from about $39M in 2025 Q2 to $63.2M in 2026 Q2, punctuated by a peak around $121.8M in 2025 Q4, signaling improved quarterly profitability despite some variability.

💰 Margins & Cash Flow

Gross Margin has been robust in the high-50s to around 60%, supporting steady profitability. Operating Margin remains modest but positive in most quarters, signaling operating leverage when occupancy/revenue scales. Net cash flow from operating activities stayed strong across the period, with quarterly figures ranging roughly from $260M to $361M, while investing activity was consistently negative and financing activity provided additional liquidity in several quarters.

🛡️ Balance Sheet & Liquidity

Total Assets around $21.7B and Liabilities near $12.2B yield Equity near $9.5B, indicating solid asset backing and a balanced capital structure. The firm shows favorable liquidity indicators (current assets roughly exceed current liabilities) and a long-term debt load in the vicinity of $10B, supported by consistent operating cash flow.

⚠️ Key Drivers & Risks

• Drivers: Stable healthcare/REIT rental cash flows and access to cost-effective financing; occupancy resilience.
• Risks: Interest-rate sensitivity and real estate cycle risk; potential refinancing risk given leverage and sector cyclicality.